This module introduces the subject of pharmacogenetics and pharmacogenomics, and explains the meaning of these terms and other common terminology used about gene expression and drugs. It looks at how use of pre-emptive pharmacogenomic testing may develop in the future and considers ethical concerns related to testing.
Contributing author: Dr Martin Duerden FRCGP, medical adviser, Diploma in Therapeutics, Cardiff University and co-author of ‘Symptoms in the Pharmacy’
This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.
We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.
